Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests.

Robiolo B, La Torre J, Maradei E, Beascoechea CP, Perez A, Seki C, Smitsaart E, Fondevila N, Palma E, Goris N, De Clercq K, Mattion N.

Vaccine. 2010 Aug 31;28(38):6235-41. doi: 10.1016/j.vaccine.2010.07.012. Epub 2010 Jul 17.

PMID:
20643090
2.

Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.

Maradei E, La Torre J, Robiolo B, Esteves J, Seki C, Pedemonte A, Iglesias M, D'Aloia R, Mattion N.

Vaccine. 2008 Dec 2;26(51):6577-86. doi: 10.1016/j.vaccine.2008.09.033.

PMID:
18835312
3.

Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology.

Mattion N, Goris N, Willems T, Robiolo B, Maradei E, Beascoechea CP, Perez A, Smitsaart E, Fondevila N, Palma E, De Clercq K, La Torre J.

Vaccine. 2009 Jan 29;27(5):741-7. doi: 10.1016/j.vaccine.2008.11.026. Epub 2008 Nov 27.

PMID:
19041355
4.

Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the "Protection against Podal Generalisation" test.

Goris N, Maradei E, D'Aloia R, Fondevila N, Mattion N, Perez A, Smitsaart E, Nauwynck HJ, La Torre J, Palma E, De Clercq K.

Vaccine. 2008 Jun 25;26(27-28):3432-7. doi: 10.1016/j.vaccine.2008.04.034. Epub 2008 May 5.

PMID:
18499310
5.

Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle.

Lavoria MÁ, Di-Giacomo S, Bucafusco D, Franco-Mahecha OL, Pérez-Filgueira DM, Capozzo AV.

Vaccine. 2012 Nov 6;30(48):6845-50. doi: 10.1016/j.vaccine.2012.09.011. Epub 2012 Sep 18.

PMID:
23000129
6.

Quantitative single serum-dilution liquid phase competitive blocking ELISA for the assessment of herd immunity and expected protection against foot-and-mouth disease virus in vaccinated cattle.

Robiolo B, La Torre J, Duffy S, Leon E, Seki C, Torres A, Mattion N.

J Virol Methods. 2010 Jun;166(1-2):21-7. doi: 10.1016/j.jviromet.2010.02.011. Epub 2010 Feb 17.

PMID:
20170683
7.

Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.

Nagendrakumar SB, Srinivasan VA, Madhanmohan M, Yuvaraj S, Parida S, Di Nardo A, Horsington J, Paton DJ.

Vaccine. 2011 Feb 24;29(10):1906-12. doi: 10.1016/j.vaccine.2010.12.127. Epub 2011 Jan 13.

PMID:
21236232
8.

Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina.

Periolo OH, Seki C, Grigera PR, Robiolo B, Fernández G, Maradei E, D'Aloia R, La Torre JL.

Vaccine. 1993;11(7):754-60.

PMID:
8393607
10.

Accuracy of traditional and novel serology tests for predicting cross-protection in foot-and-mouth disease vaccinated cattle.

Brito BP, Perez AM, Capozzo AV.

Vaccine. 2014 Jan 16;32(4):433-6. doi: 10.1016/j.vaccine.2013.12.007. Epub 2013 Dec 14.

PMID:
24342253
11.

Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.

Robiolo B, Seki C, Fondevilla N, Grigera P, Scodeller E, Periolo O, La Torre J, Mattion N.

Vaccine. 2006 Feb 13;24(7):997-1008. Epub 2005 Sep 7.

PMID:
16171905
12.

Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.

Brake DA, McIlhaney M, Miller T, Christianson K, Keene A, Lohnas G, Purcell C, Neilan J, Schutta C, Barrera J, Burrage T, Brough DE, Butman BT.

Dev Biol (Basel). 2012;134:123-33.

PMID:
22888605
13.

Assessment using ELISA of the herd immunity levels induced in cattle by foot-and-mouth disease oil vaccines.

Smitsaart EN, Zanelli M, Rivera I, Fondevila N, Compaired D, Maradei E, Bianchi T, O'Donnell V, Schudel AA.

Prev Vet Med. 1998 Jan;33(1-4):283-96.

PMID:
9500182
14.

A comparison of methods for measuring the antibody response in mice and cattle following vaccination against foot and mouth disease.

Dus Santos MJ, Wigdorovitz A, Maradei E, Periolo O, Smitsaart E, Borca MV, Sadir AM.

Vet Res Commun. 2000 May;24(4):261-73.

PMID:
10836271
15.

Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative.

Goris N, Willems T, Diev VI, Merkelbach-Peters P, Vanbinst T, Van der Stede Y, Kraft HP, Zakharov VM, Borisov VV, Nauwynck HJ, Haas B, De Clercq K.

Vaccine. 2008 Jul 23;26(31):3870-9. doi: 10.1016/j.vaccine.2008.05.013. Epub 2008 May 28.

PMID:
18555565
16.

High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.

Brehm KE, Kumar N, Thulke HH, Haas B.

Vaccine. 2008 Mar 20;26(13):1681-7. doi: 10.1016/j.vaccine.2008.01.038. Epub 2008 Feb 12.

PMID:
18313814
18.

Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.

Mattion N, König G, Seki C, Smitsaart E, Maradei E, Robiolo B, Duffy S, León E, Piccone M, Sadir A, Bottini R, Cosentino B, Falczuk A, Maresca R, Periolo O, Bellinzoni R, Espinoza A, Torre JL, Palma EL.

Vaccine. 2004 Oct 22;22(31-32):4149-62.

PMID:
15474705
20.

Application of monoclonal antibodies to quality control of foot-and-mouth disease vaccines.

Alonso A, Darsie GC, Teixeira AC, Reis JL, Mesquita JA.

Vaccine. 1994 Jun;12(8):682-6.

PMID:
8091844

Supplemental Content

Support Center